Canada
· Delayed Price · Currency is CAD Curaleaf Holdings Company Description
Curaleaf Holdings, Inc. operates a cannabis operator in the United States.
It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels.
The company is headquartered in New York, New York.
| Country | Canada |
| Founded | 2010 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,650 |
| CEO | Boris Jordan |
Contact Details
Address: 420 Lexington Avenue New York, British Columbia 10170 United States | |
| Website | curaleaf.com |
Stock Details
| Ticker Symbol | CURA |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA23126M1023 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Boris Alexis Jordan | Chief Executive Officer and Chairman |
| Joseph F. Lusardi | Executive Vice-Chairman |
| Edward Kremer | Chief Financial Officer |
| Peter Laurence Clateman J.D. | Chief Legal Officer |
| Matthew S. Darin | Special Advisor |
| Camilo Russi Lyon | Chief Investment Officer |
| Christine Taylor | Chief Accounting Officer |
| Jakob Feinstein | Manager of Investor Relations |
| James S. Shorris | Chief Compliance Officer |
| Kate Lynch | Executive Vice President of Marketing |